{"date": "2021-09-07 21:40:23.581000+00:00", "ticker": "III", "mrkt_info": {"open": 1339.0, "close": 1306.0}, "html": "<div class=\"storyContent\" lang=\"en\"><style type=\"text/css\">.storyContent * {border-color:inherit !important;outline-color:inherit !important;}</style><div class=\"tr-npp-lead\"><p>ten23 health, a biologics drug product contract development and manufacturing organisation (CDMO), has raised funds in private financing, led by 3i Group plc, a private equity firm.</p><p><span>(Republication or redistribution, including by framing or similar means, is expressly prohibited without prior written consent. Marketline shall not be liable for errors or delays in the content, or for any actions taken in reliance thereon.)</span> </p></div><div class=\"tr-npp-body\"><p class=\"tr-npp-section-title\">Deal In Brief</p><div class=\"story-table-container\"><table class=\"story-basic-table\"><tbody><tr><td>Deal Type</td><td>Private Equity</td> </tr><tr><td>Sub-Category</td><td>DIRECT INVESTMENT</td> </tr><tr><td>Deal Status</td><td>Completed: 2021-09-01</td> </tr> </tbody> </table></div><p class=\"tr-npp-section-title\">Deal Participants</p><div class=\"story-table-container\"><table class=\"story-basic-table\"><tbody><tr><td>Target (Company)</td><td>ten23 Health AG</td> </tr><tr><td>Acquirer (Company)</td><td>3i Group plc</td> </tr> </tbody> </table></div><p class=\"tr-npp-section-title\">Deal Rationale</p></div><p class=\"line-break\"><br/></p><p class=\"tr-copyright\">Copyright \u00a9 2001 Marketline. All rights reserved.</p></div>"}